Search results for "Vaccination"
New category of OTC hearing aids; FMT and monkeypox
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/10/new-category-of-otc-hearing-aids-fmt-and-monkeypox.htm
1 Oct 2022
Congress passes historic health, climate change legislation
The Inflation Reduction Act allows Medicare to negotiate some prescription drug prices for the first time and includes provisions for climate change.
https://immattersacp.org/archives/2022/10/congress-passes-historic-health-climate-change-legislation.htm
1 Oct 2022
New COVID-19 boosters authorized and recommended
The CDC has recommended the new formulations of the mRNA vaccines, targeted at the BA.4 and BA.5 lineages of the omicron variant, for adults and adolescents who last received a COVID-19 shot at least two months ago.
https://immattersacp.org/weekly/archives/2022/09/06/2.htm
6 Sep 2022
Details on recently authorized COVID-19 vaccine
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/09/details-on-recently-authorized-covid-19-vaccine.htm
1 Sep 2022
Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine
Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://immattersacp.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022
CDC releases interim monkeypox guidance, reports epidemiologic and clinical characteristics
The interim guidance focused on prevention and treatment of monkeypox in persons with HIV infection. The most frequently reported signs and symptoms from recent cases of monkeypox in the U.S. include rash (100%), fever (63%), chills (59%), and lymphadenopathy (59%).
https://immattersacp.org/weekly/archives/2022/08/16/1.htm
16 Aug 2022
New COVID-19 vaccine authorized; reviews analyze myocarditis, drug treatments
The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
https://immattersacp.org/weekly/archives/2022/07/19/4.htm
19 Jul 2022
New diabetes drug, new indication for eosinophilic esophagitis
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/07/new-diabetes-drug-new-indication-for-eosinophilic-esophagitis.htm
1 Jul 2022
Experts discuss the data on post-COVID-19 symptoms
ACP and Annals of Internal Medicine's ninth COVID-19 forum addressing postacute sequelae of COVID-19 (PASC) offered a better understanding of persistent symptoms after SARS-CoV-2 infection.
https://immattersacp.org/archives/2022/07/experts-discuss-the-data-on-post-covid-19-symptoms.htm
1 Jul 2022
Oral medications for COVID-19 underused among socially vulnerable, CDC study finds
By late May, the rate of prescriptions for molnupiravir and nirmatrelvir/ritonavir was twice as high in the highest-income U.S. ZIP codes as in the lowest, research showed. A CDC webinar on June 28 will discuss efforts to equitably distribute these treatments.
https://immattersacp.org/weekly/archives/2022/06/28/2.htm
28 Jun 2022